These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Glucocorticoid-induced osteoporosis in inflammatory bowel disease.
    Author: Lidofsky S, Smith J.
    Journal: Med Health R I; 2009 Apr; 92(4):128-30. PubMed ID: 19452756.
    Abstract:
    Osteoporosis secondary to glucocorticoid use is a potentially preventable disorder. It is the role of the physician to establish and maintain disease remission, minimize the use of glucocorticoids, and initiate measures to prevent and treat bone loss. The essentials of management include lifestyle modifications, nutritional interventions, and pharmacologic therapies. Bisphosphonates should be used when indicated.
    [Abstract] [Full Text] [Related] [New Search]